The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-Cyclobutyl-7-((3,5-difluoro-4-hydroxyphenyl)amino)-4,4-dimethyl-1,4-dihydro-2H-pyrimido[4,5-d][1,3]oxazin-2-one ID: ALA4845942
PubChem CID: 164609169
Max Phase: Preclinical
Molecular Formula: C19H20F2N4O3
Molecular Weight: 390.39
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)C1OC(=O)N(C2CCC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc21
Standard InChI: InChI=1S/C19H20F2N4O3/c1-9(2)16-12-8-22-18(23-10-6-13(20)15(26)14(21)7-10)24-17(12)25(19(27)28-16)11-4-3-5-11/h6-9,11,16,26H,3-5H2,1-2H3,(H,22,23,24)
Standard InChI Key: SBIVKMHKMKLGEE-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
11.4283 -16.5915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3096 -17.0165 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3085 -17.8361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0165 -18.2450 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0147 -16.6077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7233 -17.0129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7267 -17.8381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4391 -18.2455 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1527 -17.8323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1493 -17.0071 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6004 -18.2441 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5998 -19.0613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8937 -19.4713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8927 -20.2878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6006 -20.6978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3110 -20.2853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3085 -19.4702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8615 -18.2389 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.4413 -19.0627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4218 -15.7743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1262 -15.3601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7109 -15.3713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0198 -20.6920 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.1845 -20.6955 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.6011 -21.5149 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.8670 -19.6391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4464 -20.2154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0227 -19.6359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
6 1 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 1 1 0
3 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
9 18 2 0
8 19 1 0
1 20 1 0
20 21 1 0
20 22 1 0
16 23 1 0
14 24 1 0
15 25 1 0
19 26 1 0
26 27 1 0
27 28 1 0
28 19 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 390.39Molecular Weight (Monoisotopic): 390.1503AlogP: 4.41#Rotatable Bonds: 4Polar Surface Area: 87.58Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.28CX Basic pKa: 1.59CX LogP: 4.43CX LogD: 4.38Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.75Np Likeness Score: -0.58
References 1. Yuan Y, Xu J, Jiang L, Yu K, Ge Y, Li M, He H, Niu Q, Shi X, Fan L, Chen Z, Zhao Z, Li S, Xu Y, Wang Z, Li H.. (2021) Discovery, Optimization, and Structure-Activity Relationship Study of Novel and Potent RSK4 Inhibitors as Promising Agents for the Treatment of Esophageal Squamous Cell Carcinoma., 64 (18.0): [PMID:34496560 ] [10.1021/acs.jmedchem.1c00969 ]